Upgrade to SI Premium - Free Trial

Imperva (IMPV) Tops Q4 EPS by 29c

February 8, 2017 4:12 PM

Imperva (NASDAQ: IMPV) reported Q4 Non-GAAP EPS of $0.32, $0.29 better than the analyst estimate of $0.03. Revenue for the quarter came in at $78.4 million versus the consensus estimate of $70.21 million.

GUIDANCE:

Imperva sees Q1 2017 Non-GAAP EPS of ($0.06)-($0.02) ex-items, versus the consensus of ($0.11). Imperva sees Q1 2017 revenue of $67-69 million, versus the consensus of $66.5 million.

Sees FY 2017 Non-GAAP EPS $0.31-0.34 ex items versus consensus of $0.14. Revenues of $316-$319 million versus consensus of $305 million

For earnings history and earnings-related data on Imperva (IMPV) click here.

Categories

Earnings Guidance

Next Articles